Galapagos Ownership | Who Owns Galapagos?
Galapagos Ownership Summary
Galapagos is owned by 48.14% institutional investors, 25.35% insiders, and 26.51% retail investors. Gilead sciences is the largest institutional shareholder, holding 25.35% of GLPG shares. Fidelity Advisor Equity Growth I is the top mutual fund, with 0.65% of its assets in Galapagos shares.
GLPG Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Galapagos | 48.14% | 25.35% | 26.51% |
Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Gilead sciences | 16.71M | 25.35% | $461.73M |
Tang capital management | 3.99M | 6.06% | $111.68M |
Prosight management, lp | 1.77M | 2.69% | $49.64M |
Fmr | 1.59M | 2.42% | $43.86M |
Segall bryant & hamill | 685.87K | 1.04% | $18.86M |
Blackrock | 560.36K | 0.85% | $13.89M |
Hudson bay capital management lp | 515.00K | 0.78% | $14.41M |
Dme capital management, lp | 479.36K | 0.73% | $13.18M |
Wellington management group llp | 345.05K | 0.52% | $8.55M |
Point72 asset management | 341.50K | 0.52% | $9.56M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Gilead sciences | 16.71M | 29.77% | $461.73M |
Prosight management, lp | 1.77M | 12.11% | $49.64M |
Tang capital management | 3.99M | 5.65% | $111.68M |
Dafna capital management | 130.18K | 1.01% | $3.64M |
Dme capital management, lp | 479.36K | 0.68% | $13.18M |
Segall bryant & hamill | 685.87K | 0.26% | $18.86M |
Monaco asset management sam | 36.04K | 0.18% | $1.01M |
Ecor1 capital | 155.01K | 0.16% | $4.26M |
Barometer capital management | 16.92K | 0.13% | $473.51K |
Moody national bank trust division | 20.85K | 0.05% | $583.56K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Gilead sciences | 16.71M | 29.77% | 16.71M |
Prosight management, lp | 1.77M | 12.11% | 458.75K |
Point72 asset management | 341.50K | 0.02% | 341.50K |
Norges bank | 120.00K | 0.00% | 120.00K |
Jane street group | 110.78K | 0.00% | 99.65K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Bvf inc/il | - | - | -1.45M |
Deerfield management company, l.p. (series c) | - | - | -1.41M |
Logos global management lp | - | - | -800.00K |
Deep track capital, lp | - | - | -741.07K |
Finepoint capital lp | - | - | -656.59K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Gilead sciences | 16.71M | 29.77% | 16.71M | $461.73M |
Point72 asset management | 341.50K | 0.02% | 341.50K | $9.56M |
Norges bank | 120.00K | 0.00% | 120.00K | $3.30M |
Voloridge investment management | 85.40K | 0.01% | 85.40K | $2.39M |
Jump financial | 24.73K | 0.01% | 24.73K | $692.19K |
Sold Out
Holder | Change |
---|---|
Harbor investment advisory | -4.00 |
Jaffetilchin investment partners | -5.00 |
Northwestern mutual wealth management | -10.00 |
Cibc private wealth group | -11.00 |
Bogart wealth | -49.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 95 | 6.74% | 31,694,749 | 2.00% | 48 | 2.16% | 48 | 20.00% | 25 | -21.88% |
Mar 31, 2025 | 8 | -90.91% | 4,014,450 | -87.08% | 6 | 0.27% | 4 | -90.00% | 2 | -91.30% |
Dec 31, 2024 | 47 | -41.98% | 21,455,429 | 58.42% | 32 | 28.68% | 22 | -40.54% | 15 | -37.50% |
Sep 30, 2024 | 81 | -4.71% | 13,543,404 | -32.02% | 10 | 4.34% | 38 | -25.49% | 24 | 41.18% |
Jun 30, 2024 | 82 | -4.65% | 19,897,704 | -2.23% | 30 | 3.16% | 51 | 37.84% | 16 | -42.86% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Advisor Equity Growth I | 431.37K | 0.65% | - |
Fidelity VIP Growth Initial | 395.70K | 0.60% | - |
Fidelity Capital Appreciation | 354.70K | 0.54% | - |
Fidelity Growth Discovery | 229.55K | 0.35% | - |
iShares Biotechnology ETF | 191.90K | 0.29% | 1.64K |
Columbia VP Overseas Core 3 | 180.29K | 0.27% | 180.29K |
Segall Bryant & Hamill Sm Cp Val Ins | 113.52K | 0.17% | - |
AlphaCentric LifeSci Healthcare I | 108.50K | 0.16% | 3.50K |
AlphaCentric Life Sciences & Hlthcare I | 108.50K | 0.16% | - |
PRIMECAP Odyssey Aggressive Growth | 99.80K | 0.15% | -3.90K |
GLPG Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools